MetLife Investment Advisors »

Ligand Pharmaceuticals In shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $995k 9.9k 100.09
2024-06-30 $838k 9.9k 84.26
2023-12-31 $628k 8.8k 71.42
2023-09-30 $527k 8.8k 59.92
2023-06-30 $634k 8.8k 72.10
2023-03-31 $596k 8.1k 73.56
2022-12-31 $576k 8.6k 66.80
2022-09-30 $742k 8.6k 86.11
2022-06-30 $769k 8.6k 89.22
2022-03-31 $969k 8.6k 112.49
2021-12-31 $859k 5.6k 154.46
2021-09-30 $775k 5.6k 139.32
2021-06-30 $1.8M 14k 131.19
2021-03-31 $2.2M 14k 152.45
2020-12-31 $1.5M 15k 99.45
2020-09-30 $1.5M 16k 95.32
2020-06-30 $1.8M 16k 111.85
2020-03-31 $1.2M 17k 72.72
2019-12-31 $1.8M 18k 104.29
2019-09-30 $1.9M 20k 99.54
2019-06-30 $2.4M 21k 114.15
2019-03-31 $2.7M 22k 125.71
2018-12-31 $3.0M 22k 135.70
2018-09-30 $4.0M 15k 274.49
2018-06-30 $1.9M 9.3k 207.16
2018-03-31 $1.5M 9.3k 165.15
2017-12-31 $1.3M 9.3k 136.96